KDM4A expression is unique (Fig. S1B) being highly enriched in AML-LSC+ populations (Fig. S1C), suggesting that KDM4A is important for LSC, which are negatively correlated with AML patient survival. Here, ARHGEF1 is linked to acute myeloid leukemia.